MindWalk Holdings Corp. SEC filings HYFT
MindWalk Holdings Corp. has 287 filings in SEC EDGAR's recent list, going back to Aug 31, 2017. Its latest annual report, Form 20-F, was filed on Jul 23, 2026 for the period ended Apr 30, 2026. The most recent current report (Form 6-K) was filed on Nov 4, 2026. The company's fiscal year ends on April 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jul 30, 2026 | — |
| EFFECT | Filing | Aug 16, 2024 | — |
| D | Filing | Jul 30, 2024 | — |
| EFFECT | Filing | Jul 14, 2023 | — |
| CORRESP | Letter to the SEC | Jul 13, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 12, 2023 | — |
| SUPPL | Filing | Oct 13, 2021 | — |
| SUPPL | Filing | Feb 4, 2021 | — |
| SUPPL | Filing | Feb 3, 2021 | — |
| EFFECT | Filing | Jan 11, 2021 | — |
| SEC STAFF ACTION | Filing | Dec 29, 2020 | — |
| 40FR12B/A | Filing | Dec 28, 2020 | — |
| CERT | Filing | Dec 28, 2020 | — |
| 40FR12B/A | Filing | Dec 22, 2020 | — |
| 40FR12B/A | Filing | Nov 4, 2020 | — |
| 40FR12B/A | Filing | Oct 2, 2020 | — |
| 40FR12B | Filing | Sep 16, 2020 | — |
| D | Filing | Oct 9, 2018 | — |
| D | Filing | Jul 9, 2018 | — |
| D | Filing | Aug 31, 2017 | — |
Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- HYFT (Nasdaq)
- Fiscal year ends
- April 30
- Incorporated in
- British Columbia, Canada
- Headquarters
- Victoria
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1715925
- Former names
- ImmunoPrecise Antibodies Ltd. (until Sep 3, 2025)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.